Nephros, Inc. (NEPH)Healthcare | Medical Instruments & Supplies | South Orange, United States | NasdaqCM
4.55 USD
+0.24
(5.568%)
⇧
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 4.42 -0.13 (-0.130%) ⇩ (Aug. 28, 2026, 7:30 p.m. EDT) |
Hot Take ↕ | Aug. 22, 2026, 5:58 a.m. EDT
The immediate outlook is driven by a sharp technical rebound; the stock has surged nearly 128% year-over-year and recently broke out above its 50-day moving average, suggesting strong near-term momentum despite the low volume relative to the recent spike. However, this rally is built on a precarious foundation: the company is burning significant cash with negative operating and free cash flows, and it is currently trading at a premium valuation with a forward P/E of roughly 19x while generating no earnings yield. The lack of a dividend and the heavy reliance on debt financing to sustain operations create a fragile balance sheet that limits upside potential if growth stalls. While the recent price action indicates buyers are stepping in, the fundamental reality of cash destruction and high leverage suggests this is a speculative trade rather than a sustainable investment thesis. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.124455 |
| MSTL | 0.145472 |
| AutoETS | 0.153679 |
| AutoARIMA | 0.155503 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 33% |
| H-stat | 10.68 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.153 |
| Excess Kurtosis | -0.93 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 7.286 |
| Revenue per Share | 1.939 |
| Market Cap | 49,413,548 |
| Trailing P/E | 26.76 |
| Forward P/E | 21.67 |
| Beta | 1.53 |
| Profit Margins | 8.38% |
| Website | https://www.nephros.com |
| Attribute | Value |
|---|---|
| 52 Week Change | 0.02619052 |
| Address1 | 380 Lackawanna Place |
| All Time High | 1,128.6 |
| All Time Low | 0.9 |
| Ask | 4.34 |
| Ask Size | 1 |
| Average Analyst Rating | 2.0 - Buy |
| Average Daily Volume10 Day | 43,520 |
| Average Daily Volume3 Month | 18,730 |
| Average Volume | 18,730 |
| Average Volume10Days | 43,520 |
| Beta | 1.525 |
| Bid | 4.46 |
| Bid Size | 1 |
| Book Value | 1.102 |
| City | South Orange |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 4.55 |
| Current Ratio | 4.066 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 4.6188 |
| Day Low | 4.4 |
| Debt To Equity | 7.286 |
| Display Name | Nephros |
| Dividend Date | 1,562,716,800 |
| Earnings Call Timestamp End | 1,786,048,200 |
| Earnings Call Timestamp Start | 1,786,048,200 |
| Earnings Growth | 4.5 |
| Earnings Quarterly Growth | 4.051 |
| Earnings Timestamp | 1,786,046,400 |
| Earnings Timestamp End | 1,793,908,800 |
| Earnings Timestamp Start | 1,793,908,800 |
| Ebitda | 1,763,000 |
| Ebitda Margins | 0.085080005 |
| Enterprise To Ebitda | 25.859 |
| Enterprise To Revenue | 2.2 |
| Enterprise Value | 45,588,544 |
| Eps Current Year | 0.17 |
| Eps Forward | 0.21 |
| Eps Trailing Twelve Months | 0.17 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 3.7626 |
| Fifty Day Average Change | 0.78740025 |
| Fifty Day Average Change Percent | 0.20927025 |
| Fifty Two Week Change Percent | 2.619052 |
| Fifty Two Week High | 6.42 |
| Fifty Two Week High Change | -1.8699999 |
| Fifty Two Week High Change Percent | -0.29127723 |
| Fifty Two Week Low | 2.66 |
| Fifty Two Week Low Change | 1.8900001 |
| Fifty Two Week Low Change Percent | 0.71052635 |
| Fifty Two Week Range | 2.66 - 6.42 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,095,773,400,000 |
| Float Shares | 9,405,733 |
| Forward Eps | 0.21 |
| Forward P E | 21.666668 |
| Free Cashflow | -1,451,375 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 36 |
| Fullday Change | 0.24 |
| Fullday Change Percent | 5.56845 |
| Fullday Price | 4.42 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.61263 |
| Gross Profits | 12,695,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.12892 |
| Held Percent Institutions | 0.48933 |
| Implied Shares Outstanding | 10,860,120 |
| Industry | Medical Instruments & Supplies |
| Industry Disp | Medical Instruments & Supplies |
| Industry Key | medical-instruments-supplies |
| Ir Website | http://www.nephros.com/investors/stock-info-analysis/ |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,562,716,800 |
| Last Split Factor | 1:9 |
| Long Business Summary | Nephros, Inc., a commercial-stage company, develops and sells water filtration solutions for medical and commercial applications in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in foodservice and hospitality, and other healthcare facilities. The company also manufactures and sells water filters that enhance the taste and odor of water; reduce biofilm and scale build-up; and remove cysts, particulates, and lead from water systems. It markets its products to food service and hospitality sectors including quick-service restaurants, convenience stores, and restaurants. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey. |
| Long Name | Nephros, Inc. |
| Market | us_market |
| Market Cap | 49,413,548 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_3661033 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | 1,736,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 46,807,117 |
| Number Of Analyst Opinions | 3 |
| Open | 4.43 |
| Operating Cashflow | -661,000 |
| Operating Margins | 0.2016 |
| Payout Ratio | 0.0 |
| Phone | 201 343 5202 |
| Post Market Change | -0.13000011 |
| Post Market Change Percent | -2.8571453 |
| Post Market Price | 4.42 |
| Post Market Time | 1,787,959,805 |
| Previous Close | 4.31 |
| Price Eps Current Year | 26.764708 |
| Price Hint | 4 |
| Price To Book | 4.1288567 |
| Price To Sales Trailing12 Months | 2.3845935 |
| Profit Margins | 0.083780006 |
| Quick Ratio | 2.629 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | buy |
| Recommendation Mean | 2.0 |
| Region | US |
| Regular Market Change | 0.24 |
| Regular Market Change Percent | 5.56845 |
| Regular Market Day High | 4.6188 |
| Regular Market Day Low | 4.4 |
| Regular Market Day Range | 4.4 - 4.6188 |
| Regular Market Open | 4.43 |
| Regular Market Previous Close | 4.31 |
| Regular Market Price | 4.55 |
| Regular Market Time | 1,787,947,201 |
| Regular Market Volume | 21,350 |
| Return On Assets | 0.07327 |
| Return On Equity | 0.16099001 |
| Revenue Growth | 0.362 |
| Revenue Per Share | 1.939 |
| Sand P52 Week Change | 0.20504117 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 10,860,120 |
| Shares Percent Shares Out | 0.0041 |
| Shares Short | 44,763 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 31,336 |
| Short Name | Nephros, Inc. |
| Short Percent Of Float | 0.0067000003 |
| Short Ratio | 2.74 |
| Source Interval | 15 |
| State | NJ |
| Symbol | NEPH |
| Target High Price | 8.0 |
| Target Low Price | 4.75 |
| Target Mean Price | 6.25 |
| Target Median Price | 6.0 |
| Total Cash | 4,697,000 |
| Total Cash Per Share | 0.432 |
| Total Debt | 872,000 |
| Total Revenue | 20,722,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | 0.17 |
| Trailing P E | 26.764708 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 3.91595 |
| Two Hundred Day Average Change | 0.63405013 |
| Two Hundred Day Average Change Percent | 0.16191477 |
| Type Disp | Equity |
| Volume | 21,350 |
| Website | https://www.nephros.com |
| Zip | 7,079 |